$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2018 Q2 Form 10-Q Financial Statement

#000156459018019930 Filed on August 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $727.4K $9.342M
YoY Change -92.21% 23502.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.590M $6.990M
YoY Change -34.33% -23.52%
% of Gross Profit
Research & Development $12.05M $6.910M
YoY Change 74.38% -26.67%
% of Gross Profit
Depreciation & Amortization $751.1K $1.100M
YoY Change -31.72% 37.5%
% of Gross Profit
Operating Expenses $16.65M $15.06M
YoY Change 10.56% 59.78%
Operating Profit -$15.92M -$5.714M
YoY Change 178.6% -70.46%
Interest Expense $313.7K $131.4K
YoY Change 138.81% 285.18%
% of Operating Profit
Other Income/Expense, Net $313.7K $0.00
YoY Change -100.0%
Pretax Income -$15.61M -$5.520M
YoY Change 182.73% -71.58%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$15.61M -$5.520M
YoY Change 182.73% -71.58%
Net Earnings / Revenue -2145.53% -59.08%
Basic Earnings Per Share -$0.18
Diluted Earnings Per Share -$0.18 -$73.83K
COMMON SHARES
Basic Shares Outstanding 87.63M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.50M $75.10M
YoY Change -19.44% 68.39%
Cash & Equivalents $28.00M $38.38M
Short-Term Investments $32.50M $36.80M
Other Short-Term Assets $1.400M $1.800M
YoY Change -22.22% -63.27%
Inventory
Prepaid Expenses
Receivables $0.00 $900.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $61.90M $77.90M
YoY Change -20.54% 57.06%
LONG-TERM ASSETS
Property, Plant & Equipment $14.00M $16.10M
YoY Change -13.04% 30.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $17.70M
YoY Change
Other Assets $100.0K $200.0K
YoY Change -50.0% 63.49%
Total Long-Term Assets $51.00M $37.20M
YoY Change 37.1% 3.52%
TOTAL ASSETS
Total Short-Term Assets $61.90M $77.90M
Total Long-Term Assets $51.00M $37.20M
Total Assets $112.9M $115.1M
YoY Change -1.91% 34.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $3.200M
YoY Change -31.25% -46.18%
Accrued Expenses $3.300M $3.000M
YoY Change 10.0% -52.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K
YoY Change 0.0% -50.0%
Total Short-Term Liabilities $7.100M $20.30M
YoY Change -65.02% 36.79%
LONG-TERM LIABILITIES
Long-Term Debt $2.200M $2.400M
YoY Change -8.33% -20.0%
Other Long-Term Liabilities $1.900M $2.800M
YoY Change -32.14% -66.27%
Total Long-Term Liabilities $4.100M $5.200M
YoY Change -21.15% -53.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.100M $20.30M
Total Long-Term Liabilities $4.100M $5.200M
Total Liabilities $10.60M $25.00M
YoY Change -57.6% -2.34%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $180.2K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $102.3M $90.10M
YoY Change
Total Liabilities & Shareholders Equity $112.9M $115.1M
YoY Change -1.91% 34.62%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$15.61M -$5.520M
YoY Change 182.73% -71.58%
Depreciation, Depletion And Amortization $751.1K $1.100M
YoY Change -31.72% 37.5%
Cash From Operating Activities -$14.40M -$10.40M
YoY Change 38.46% -43.17%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$1.100M
YoY Change -81.82% 83.33%
Acquisitions
YoY Change
Other Investing Activities -$28.70M -$11.80M
YoY Change 143.22% -216.83%
Cash From Investing Activities -$28.90M -$12.90M
YoY Change 124.03% -235.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.500M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -14.40M -10.40M
Cash From Investing Activities -28.90M -12.90M
Cash From Financing Activities 1.500M 0.000
Net Change In Cash -41.80M -23.30M
YoY Change 79.4% 253.03%
FREE CASH FLOW
Cash From Operating Activities -$14.40M -$10.40M
Capital Expenditures -$200.0K -$1.100M
Free Cash Flow -$14.20M -$9.300M
YoY Change 52.69% -47.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
17672658
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
141918
CY2017Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
440580
us-gaap Revenues
Revenues
22693923
CY2018Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5519741
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-5519741
us-gaap Profit Loss
ProfitLoss
-43689207
us-gaap Profit Loss
ProfitLoss
-23648409
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
74772103
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12309
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23674244
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5818119
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1032058
arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1237430
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-54668
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.25
us-gaap Share Based Compensation
ShareBasedCompensation
5818119
us-gaap Share Based Compensation
ShareBasedCompensation
5881901
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3470880
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3535915
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20464439
us-gaap Revenues
Revenues
4887321
CY2017Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
16647094
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
15056662
CY2017Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
131358
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12177652
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87854651
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
180224
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
578642206
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87854651
CY2017Q2 us-gaap Revenues
Revenues
9342498
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3338
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74785426
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74785426
CY2018Q2 us-gaap Revenues
Revenues
727375
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3097287
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43689207
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23648409
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
82149381
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73603852
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
36974625
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
37363207
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36570
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25835
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15634620
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5507432
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43725777
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-15606017
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87634435
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-28603
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
425107
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
425107
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
862313
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-582373
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
140041
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-52822
us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-856253
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3176551
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4326540
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8796246
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1910782
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4353087
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4652873
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5337827
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-312003
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-264921
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44543099
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14735498
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
711779
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7810754
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
47174620
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
39904676
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
37204420
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3289963
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10681979
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44425467
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
154986
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
97145
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54667
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
417140
arwr Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
2006515
arwr Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
272818
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56585035
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12419119
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58381897
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3156819
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-46983313
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85366448
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38383135
us-gaap Interest Paid Net
InterestPaidNet
131429
us-gaap Interest Paid Net
InterestPaidNet
142033
arwr Proceeds From Refundable Income Tax Credits
ProceedsFromRefundableIncomeTaxCredits
3635016
us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains several bank accounts at two financial institutions for its operations. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per institution. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p></div>
arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
12500000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2018Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2017Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
600334
CY2017Q3 arwr Research Equipment
ResearchEquipment
9660960
CY2017Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
132078
CY2017Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12208380
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22601752
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7088733
CY2018Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
50157366
CY2018Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
335334
CY2018Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
49822032
CY2017Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
40769539
CY2017Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
334755
CY2017Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
40434784
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1275322
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1275322
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
425108
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700429
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700429
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700429
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700429
CY2018Q2 arwr Finite Lived Intangible Assets Amortization Expense Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseYearSix
1700429
CY2018Q2 arwr Finite Lived Intangible Assets Amortization Expense After Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix
10261864
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 arwr Facility Rent Expense
FacilityRentExpense
353400
CY2017Q2 arwr Facility Rent Expense
FacilityRentExpense
328600
arwr Facility Rent Expense
FacilityRentExpense
1041400
arwr Facility Rent Expense
FacilityRentExpense
1126500
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
384250
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1435409
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1044431
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1070496
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1097168
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4669328
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9701082
CY2018Q2 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
53520
CY2018Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
223820
CY2018Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
240258
CY2018Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
257903
CY2018Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
276845
CY2018Q2 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
1326192
CY2018Q2 us-gaap Contractual Obligation
ContractualObligation
2378538
CY2018Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q2 us-gaap Purchase Obligation
PurchaseObligation
19200000
CY2018Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
5000000
CY2018Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
14200000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5549543
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
739000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
233357
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
283627
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4174006
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.00
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.71
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.97
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.64
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.53
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
45386696
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
30543795
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.021
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.028
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.023
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.33
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each outstanding RSU will be exchanged for one share of the Company’s Common Stock. RSU recipients may elect to net share settle upon vesting, in which case the Company pays the employee’s income taxes due upon vesting and withholds a number of shares of Common Stock of equal value. RSU awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.

Files In Submission

Name View Source Status
0001564590-18-019930-index-headers.html Edgar Link pending
0001564590-18-019930-index.html Edgar Link pending
0001564590-18-019930.txt Edgar Link pending
0001564590-18-019930-xbrl.zip Edgar Link pending
arwr-10q_20180630.htm Edgar Link pending
arwr-20180630.xml Edgar Link completed
arwr-20180630.xsd Edgar Link pending
arwr-20180630_cal.xml Edgar Link unprocessable
arwr-20180630_def.xml Edgar Link unprocessable
arwr-20180630_lab.xml Edgar Link unprocessable
arwr-20180630_pre.xml Edgar Link unprocessable
arwr-ex311_9.htm Edgar Link pending
arwr-ex312_7.htm Edgar Link pending
arwr-ex321_6.htm Edgar Link pending
arwr-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending